You are here: Home » PTI Stories » National » News
Business Standard

Lupin gets USFDA approval for generic contraceptive drug

Press Trust of India  |  New Delhi 

today said it has received approval from the US health regulator to market Drospirenone, Ethinyl Estradiol, Levomefolate Calcium tablets, used to prevent pregnancy, in the American market.

The company has received final approval from the Food and Drug Administration (FDA) to market its product which is a generic version of Bayer HealthCare Pharmaceutical Inc's tablets, said in a statement.

The product is indicated for use by women to prevent pregnancy and treat symptoms of (PMDD).

The drug is also used to treat for women at least 14 years old besides to raise folate levels in women who choose to use an oral contraceptive for

According to IQVIA MAT April 2018 data, Drospirenone, Ethinyl Estradiol, and Levomefolate Calcium Tablets, 3 mg/0.02 mg/0.451 mg and 0.451 mg had annual sales of around USD 82.2 million in the US.

shares today ended 3.35 per cent up at Rs 898.70 on the

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Thu, June 14 2018. 16:05 IST